GSDME and hepatocellular carcinoma: Furthermore, when HCC cells were treated with Lenvatinib, the level of GSDME palmitoylation increased significantly compared to the control group (Figure 4c-d), indicating that Lenvatinib promotes GSDME palmitoylation.